focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Fri, 23rd Jan 2015 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES REED ELSEVIER PRICE TARGET TO 1275 (1105) PENCE - 'BUY'
----------
SOCGEN RAISES WPP PRICE TARGET TO 1685 (1530) PENCE - 'BUY'
----------
SOCGEN RAISES PEARSON PRICE TARGET TO 1220 (1105) PENCE - 'HOLD'
----------
SOCGEN RAISES ITV PRICE TARGET TO 240 (220) PENCE - 'HOLD'
----------
SOCGEN RAISES SKY PLC PRICE TARGET TO 1110 (1045) PENCE - 'BUY'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 300 (370) PENCE - 'BUY'
----------
BERNSTEIN CUTS HSBC PRICE TARGET TO 660 (800) PENCE - 'OUTPERFORM'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4800 (4240) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1620 (1540) PENCE - 'HOLD'
----------
BERENBERG CUTS INTERTEK PRICE TARGET TO 2375 (2800) PENCE - 'HOLD'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 939 (916) PENCE - 'OVERWEIGHT'
----------
TRADERS: GOLDMAN CUTS ANTOFAGASTA TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 710 (755) PENCE - 'NEUTRAL'
----------
TRADERS: GOLDMAN RAISES ANGLO AMERICAN TO 'NEUTRAL' ('SELL')
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1120 (1340) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS EXPERIAN TO 'NEUTRAL' ('BUY')
----------
CITIGROUP RAISES ST JAMES'S PLACE PRICE TARGET TO 1000 (870) PENCE - 'BUY'
----------
NUMIS RAISES ST JAMES'S PLACE PRICE TARGET TO 980 (850) PENCE - 'ADD'
----------
CITIGROUP CUTS WEIR GROUP PRICE TARGET TO 1750 (1900) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES IAG PRICE TARGET TO 7.50 (6.60) EUR - 'OVERWEIGHT'
----------
NUMIS RAISES WHITBREAD PRICE TARGET TO 5600 (5150) PENCE - 'ADD'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1190 (1110) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS TARGET TO 2600 (2200) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1550 (1870) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3400 (3500) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 1600 (1510) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES BALFOUR BEATTY TO 'ADD' ('HOLD') - TARGET 230 PENCE
----------
SOCGEN RAISES INFORMA TO 'BUY' ('HOLD') - TARGET 585 (500) PENCE
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 950 (1300) PENCE - 'BUY'
----------
BERENBERG CUTS OXFORD INSTRUMENTS TO 'HOLD' ('BUY') - TARGET 950 (1360) PENCE

BARCLAYS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 860 (1140) PENCE - 'EQUALWEIGHT'

JPMORGAN CUTS OXFORD INSTRUMENTS TARGET TO 1200 (1350) PENCE - 'OVERWEIGHT'

UBS CUTS RENTOKIL INITIAL TO 'SELL' ('NEUTRAL') - TARGET 112 PENCE
----------
UBS CUTS OPHIR ENERGY PRICE TARGET TO 150 (230) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ELECTROCOMPONENTS PRICE TARGET TO 210 (229) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS CUTS PREMIER FARNELL PRICE TARGET TO 188 (205) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: JPMORGAN CUTS TELECITY GROUP TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: MORGAN STANLEY CUTS MICHAEL PAGE TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
UBS CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS CRODA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2770 (2820) PENCE
----------
EXANE BNP CUTS ELEMENTIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 300 PENCE
----------
CITIGROUP RAISES HENDERSON GROUP PLC PRICE TARGET TO 246 (218) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HAYS PRICE TARGET TO 165 (160) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS TELECITY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 900 (925) PENCE
----------
JPMORGAN RAISES LADBROKES PRICE TARGET TO 110 (95) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 635 (615) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SSP GROUP PRICE TARGET TO 320 (310) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 335 (365) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 530 (960) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
SOCGEN CUTS DAILY MAIL PRICE TARGET TO 720 (740) PENCE - 'SELL'
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 130 (125) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS FERREXPO PRICE TARGET TO 80 (110) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS PETROPAVLOVSK PRICE TARGET TO 9 (10) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.